Filing Details
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:SPRB
SPRUCE BIOSCIENCES, INC. (SPRB) Files Quarterly Report for Q0
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on August 12, 2026.
At publication ·
What changed
SPRUCE BIOSCIENCES, INC. (NASDAQ:SPRB) · 10q filed
- Form
- 10-Q
At a glance
Key takeaways
- Spruce Biosciences filed its quarterly report (Form 10-Q) on August 12, 2026, providing unaudited financial statements and management commentary on recent performance.
- The company's stock trades at $47.07 with a market capitalization of $51.6 million.
- The article does not disclose Q0 revenue figures, limiting visibility into the company's financial performance for the period.
Market Context
SPRUCE BIOSCIENCES, INC.'s stock currently trades at $47.07 with a market capitalization of $51.6M.
The 10-Q provides SPRUCE BIOSCIENCES, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for SPRUCE BIOSCIENCES, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View SPRB Stock Page
Frequently Asked Questions
Where can I read SPRB's SEC filings?
Browse all filings on our SPRB SEC filings page.
What types of SEC filings does SPRUCE BIOSCIENCES, INC. file?
Public companies like SPRUCE BIOSCIENCES, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.